NXSCF
Price
$0.11
Change
-$0.00 (-0.00%)
Updated
Sep 24 closing price
OASMY
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
34 days until earnings call
Ad is loading...

NXSCF vs OASMY

Header iconNXSCF vs OASMY Comparison
Open Charts NXSCF vs OASMYBanner chart's image
NEXT SCIENCE
Price$0.11
Change-$0.00 (-0.00%)
Volume$36.46K
CapitalizationN/A
VIVESTO AB
Price$0.05
Change-$0.00 (-0.00%)
Volume$27K
CapitalizationN/A
View a ticker or compare two or three
NXSCF vs OASMY Comparison Chart
Loading...
VS
NXSCF vs. OASMY commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXSCF is a Hold and OASMY is a Hold.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (NXSCF: $0.13 vs. OASMY: $0.05)
Brand notoriety: NXSCF and OASMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NXSCF: 24% vs. OASMY: 10%
Market capitalization -- NXSCF: $82.26M vs. OASMY: $12.82M
NXSCF [@Pharmaceuticals: Other] is valued at $82.26M. OASMY’s [@Pharmaceuticals: Other] market capitalization is $12.82M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXSCF’s FA Score shows that 0 FA rating(s) are green whileOASMY’s FA Score has 0 green FA rating(s).

  • NXSCF’s FA Score: 0 green, 5 red.
  • OASMY’s FA Score: 0 green, 5 red.
According to our system of comparison, OASMY is a better buy in the long-term than NXSCF.

Price Growth

NXSCF (@Pharmaceuticals: Other) experienced а -1.76% price change this week, while OASMY (@Pharmaceuticals: Other) price change was +2.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

OASMY is expected to report earnings on Nov 21, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
NXSCF($82.3M) has a higher market cap than OASMY($12.8M). OASMY YTD gains are higher at: 150.000 vs. NXSCF (-36.238). NXSCF has higher annual earnings (EBITDA): -11.94M vs. OASMY (-88.39M). OASMY has more cash in the bank: 119M vs. NXSCF (7.37M). NXSCF has less debt than OASMY: NXSCF (276K) vs OASMY (7.89M). NXSCF has higher revenues than OASMY: NXSCF (10.4M) vs OASMY (1.02M).
NXSCFOASMYNXSCF / OASMY
Capitalization82.3M12.8M643%
EBITDA-11.94M-88.39M14%
Gain YTD-36.238150.000-24%
P/E RatioN/AN/A-
Revenue10.4M1.02M1,025%
Total Cash7.37M119M6%
Total Debt276K7.89M3%
FUNDAMENTALS RATINGS
OASMY: Fundamental Ratings
OASMY
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

NXSCF and

Correlation & Price change

A.I.dvisor tells us that NXSCF and KMDA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXSCF and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXSCF
1D Price
Change %
NXSCF100%
-7.59%
KMDA - NXSCF
25%
Poorly correlated
+1.04%
APNHY - NXSCF
20%
Poorly correlated
N/A
OILFF - NXSCF
12%
Poorly correlated
-4.35%
OMID - NXSCF
6%
Poorly correlated
N/A
PCLOF - NXSCF
3%
Poorly correlated
-17.93%
More

OASMY and

Correlation & Price change

A.I.dvisor tells us that OASMY and PCLOF have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OASMY and PCLOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OASMY
1D Price
Change %
OASMY100%
+2.04%
PCLOF - OASMY
2%
Poorly correlated
-17.93%
OMID - OASMY
2%
Poorly correlated
N/A
PAIOF - OASMY
1%
Poorly correlated
N/A
NXSCF - OASMY
0%
Poorly correlated
-7.59%
PHCUF - OASMY
0%
Poorly correlated
N/A
More